If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Area of Expertise

Dr. Dong’s research interests include pharmaceutical analysis/bioanalysis, drug formulation, and delivery. She develops novel formulation nanotechnologies to improve bioavailability of oral drugs and deliver macromolecules such as siRNAs and proteins. In addition to novel drug formulations, her lab evaluates these formulations for therapeutic efficacy (e.g. anticancer drugs), pharmacokinetics, and biodistribution. Thus, her lab has the capacity to perform bioassays for both small molecules and macromolecules. Additionally, she collaborates with the clinical pharmacy to test stability of compounding medications and Y-site compatibility.

Education/Academic qualification

PhD in Pharmaceutical Sciences, University of Kentucky

MS in Applied Chemistry, East China University of Science and Technology

BS in Industrial Analysis

Fingerprint Dive into the research topics where Xiaowei Dong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Nanoparticles Medicine & Life Sciences
Multiple Drug Resistance Medicine & Life Sciences
Lipids Medicine & Life Sciences
Ritonavir Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Nerve Growth Factor Medicine & Life Sciences
HDL Lipoproteins Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2016

Research Output 2006 2018

  • 638 Citations
  • 6 h-Index
  • 9 Article
  • 2 Review article
22 Citations (Scopus)

Current strategies for brain drug delivery

Dong, X., 1 Jan 2018, In : Theranostics. 8, 6, p. 1481-1493 13 p.

Research output: Contribution to journalReview articleResearchpeer-review

Blood-Brain Barrier
Brain
Pharmaceutical Preparations
Nanoparticles
Multiple Sclerosis

Development and characterization of docetaxel-loaded nanoparticles for docetaxel-resistant castration-resistant prostate cancer

Tanaudommongkon, A., Tanaudommongkon, I., Prathipati, P., Nguyen, J. & Dong, X., 1 Jan 2017, In : Journal of Nanoscience and Nanotechnology. 17, 6, p. 3920-3926 7 p.

Research output: Contribution to journalArticleResearchpeer-review

docetaxel
Castration
Nanoparticles
Prostatic Neoplasms
cancer
1 Citation (Scopus)

Preparation and characterization of novel HDL-mimicking nanoparticles for nerve growth factor encapsulation

Zhu, J. & Dong, X., 22 May 2017, In : Journal of Visualized Experiments. 2017, 123, e55584.

Research output: Contribution to journalArticleResearchpeer-review

Lipoproteins
Nerve Growth Factor
HDL Lipoproteins
Encapsulation
Nanoparticles
4 Citations (Scopus)

Development and in vivo evaluation of child-friendly lopinavir/ritonavir pediatric granules utilizing novel in situ self-assembly nanoparticles

Pham, K., Li, D., Guo, S., Penzak, S. R. & Dong, X., 28 Mar 2016, In : Journal of Controlled Release. 226, p. 88-97 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Lopinavir
Ritonavir
Nanoparticles
Pediatrics
Nanotechnology
3 Citations (Scopus)

Development of novel HDL-mimicking α-tocopherol-coated nanoparticles to encapsulate nerve growth factor and evaluation of biodistribution

Prathipati, P., Zhu, J. & Dong, X., 1 Nov 2016, In : European Journal of Pharmaceutics and Biopharmaceutics. 108, p. 126-135 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Tocopherols
Nerve Growth Factor
HDL Lipoproteins
Nanoparticles
Ions